Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models
Yuncang Yuan, Jiawei Fan, Dandan Liang, et al.
Translational Oncology (2023) Vol. 39, pp. 101803-101803
Open Access | Times Cited: 13

Showing 13 citing articles:

Multidimensional pan-cancer analysis of HSPA5 and its validation in the prognostic value of bladder cancer
Yaxuan Wang, Jinfeng Wang, Yang Liu, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27184-e27184
Open Access | Times Cited: 19
Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target
Binbin Hu, Guihong Liu, Kejia Zhao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer
Haoyu Tang, Yizhi Cao, Yiwei Zhou, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
Cell-Surface GRP78-Targeted Chimeric Antigen Receptor T Cells Eliminate Lung Cancer Tumor Xenografts
Shijie Wang, Wenwen Wei, Yuncang Yuan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 564-564
Open Access | Times Cited: 5
Unlocking the potential of chimeric antigen receptor T cell engineering immunotherapy: Long road to achieve precise targeted therapy for hepatobiliary pancreatic cancers
Hongli Gao, Lianyue Qu, Mu Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 297, pp. 139829-139829
Closed Access
GRP78 in Glioma Progression and Therapy: Implications for Targeted Approaches
Yang Yue, Wen Li, Yu Zhao, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 382-382
Open Access
GRP78 Nanobody‐Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy
Huifang Wang, Runhua Zhou, Chengchao Xu, et al.
Advanced Science (2025)
Open Access
Complete remission of advanced pancreatic cancer induced by claudin18.2-targeted CAR-T cell therapy: a case report
Guocheng Zhong, Xiaomin Zhang, Zheng Guo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
A novel bispecific T-cell engager using the ligand-target csGRP78 against acute myeloid leukemia
Xiaozhu Zeng, Hang Zhang, Jing Guo, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Cancer Immunotherapies Targeting Cancer Stem Cells: Concepts, Applications, and Advances
Pooya Farhangnia, Mohammad-Reza Shokri, Mahzad Akbarpour, et al.
Interdisciplinary cancer research (2024)
Closed Access
Research advances in protein lysine 2‐hydroxyisobutyrylation: From mechanistic regulation to disease relevance
Jinglei Huang, Hui Peng, Diqi Yang
Journal of Cellular Physiology (2024)
Closed Access
Immunoglobulin-binding protein and Toll-like receptors in immune landscape of breast cancer
Priyamvada Bhamidipati, Ganji Purnachandra Nagaraju, Rama Rao Malla
Life Sciences (2024), pp. 123196-123196
Closed Access
Page 1

Scroll to top